68Ga-FAPI-XT-117

N/A

Report date: 2025/09/22 13:59:20

Base Information

Drug Name68Ga-FAPI-XT-117
Drug Alias Name68Ga-FAPI-XT117
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug Conjugates
Mechanisms of ActionFibroblast activation protein alpha inhibitors
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Xiantong International Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Xiantong International Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A